Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development
- 1 March 2014
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 19 (3), 348-355
- https://doi.org/10.1016/j.drudis.2013.11.015
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCareDrug Discovery Today, 2012
- Four disruptive strategies for removing drug discovery bottlenecksDrug Discovery Today, 2012
- Drug discovery in pharmaceutical industry: productivity challenges and trendsDrug Discovery Today, 2012
- Drug discovery in the next decade: innovation needed ASAPDrug Discovery Today, 2011
- Open partnering of integrated drug discovery: continuing evolution of the pharmaceutical modelDrug Discovery Today, 2011
- The patent cliff steepensNature Reviews Drug Discovery, 2010
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- Pharmaceutical industry financial performanceNature Reviews Drug Discovery, 2009
- Lessons from 60 years of pharmaceutical innovationNature Reviews Drug Discovery, 2009
- Drug developer strategies to boost competitivenessNature Reviews Drug Discovery, 2007